MRSN: SEC Form S-8 POS filed by Mersana Therapeutics Inc.
Stocks in this Quantisnow insightHealth Care
Historical context for MRSN
Across the 3 sessions after earlier MRSN headlines, the stock closed higher 3 times and lower 0 times, with a median move of 2.4% in either direction. This shows timing only: many things move a stock in a session, and these figures do not show that any headline caused a move.
| Session | Earlier headline | MRSN | SPY |
|---|---|---|---|
| Nov 14, 2025 | Mersana Therapeutics Provides Business Update and Announces Third Quarter 2025 Financial Results | +1.8% | -0.0% |
| Nov 13, 2025 | Day One Biopharmaceuticals to Acquire Mersana Therapeutics | +209.2% | -1.7% |
| Nov 10, 2025 | Mersana Therapeutics to Host Third Quarter 2025 Conference Call on November 14, 2025 | +2.4% | +1.6% |
Quantisnow market dataNASDAQ
MRSN
Mersana Therapeutics Inc.
- Market cap
- 30-day
- Sector
- Health Care
- Industry
- Biotechnology: Pharmaceutical Preparations
- Listed since
- 2017
Get push alerts for MRSN
Full MRSN profile on Quantisnow Follow MRSN and get a push notification the moment its next story breaks.
Original source Picked up and delivered by Quantisnow in real time